This exciting launch coincides with MolecuLight's significant presence at the upcoming Symposium on Advanced Wound Care (SAWC) Spring meeting in Grapevine, TX, from April 30 to May 3, 2025, where the ...
PITTSBURGH, Oct. 1, 2024 /PRNewswire/ -- MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria and digital wound measurement, announced ...
MolecuLight Corp., is a privately owned medical imaging company with a global presence that manufactures and commercializes the MolecuLight i:X ® and DX ™ wound imaging devices. These are the only ...
PITTSBURGH, Jan. 29, 2026 /PRNewswire/ - MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device ...
PITTSBURGH , Sept. 4, 2025 /PRNewswire/ - MolecuLight Corp., the global leader in point-of-care fluorescence imaging for wound care, announces continued innovation in wound care technology and its ...
PITTSBURGH, Aug. 27, 2024 /PRNewswire/ - MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria and digital wound measurement, announced ...
PITTSBURGH, April 29, 2025 /PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results